Apyx Medical (APYX) Interest Coverage Ratio Growth (3y) (2014 - 2026)
Apyx Medical (APYX) Interest Coverage Ratio Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -10.66% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 61.88% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 46.62% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -36.73% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -2.41% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 100.22% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 9.28% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -35.05% |
| 10 | Apyx Medical | 170.16 Mn | 139.02 Mn | 7.93 Mn | 83.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83.03% |
| Dec 31, 2025 | 25.99% |
| Sep 30, 2025 | 97.37% |
| Jun 30, 2025 | 94.71% |
| Mar 31, 2025 | 91.92% |
| Dec 31, 2024 | 88.43% |
| Sep 30, 2024 | 93.38% |
| Jun 30, 2024 | 93.87% |
| Mar 31, 2024 | 92.22% |
| Dec 31, 2023 | 23.73% |
| Sep 30, 2023 | 85.06% |
| Jun 30, 2023 | 85.66% |
| Mar 31, 2023 | 73.22% |
| Dec 31, 2022 | -374.00% |
| Sep 30, 2022 | -166.93% |
| Jun 30, 2022 | -84.76% |
| Dec 31, 2021 | 33.81% |
| Sep 30, 2021 | -224.46% |
| Jun 30, 2021 | -196.97% |
| Mar 31, 2021 | -145.68% |